Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
about
Critical evaluation of urinary markers for bladder cancer detection and monitoringMultiplex protein signature for the detection of bladder cancer in voided urine samplesUrine-based assays for the detection of bladder cancer.Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladderUrine cytology and adjunct markers for detection and surveillance of bladder cancer.The origins of urothelial carcinoma.Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic studyNational practice recommendations for hematuria: how to evaluate in the absence of strong evidence?Rationale for an early detection program for bladder cancerFISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers.Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trialEarly diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.Urine telomerase for diagnosis and surveillance of bladder cancer.A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.Basics of cytology.A multiplex immunoassay for the non-invasive detection of bladder cancerFluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens.UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary studyClinical states model for biomarkers in bladder cancerBiological markers in the diagnosis of recurrent bladder cancer: an overview.Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer.The current role of telomerase in the diagnosis of bladder cancer.Bladder cancer biomarkers and their role in surveillance and screening.The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.Molecular markers for detection, surveillance and prognostication of bladder cancer.Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomographyReflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.A retrospective review of UroVysion fish interpretations over 8.6 years: a major shift in the patient test population.Diagnostic significance of allelic imbalance in cancer.Urinary markers for bladder cancer.Urothelial Bladder Cancer Urinary Biomarkers.Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria.Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.A pilot study of urinary microRNA as a biomarker for urothelial cancer.Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens.
P2860
Q24654929-8ADF4157-8955-44E5-9C0B-0E464DD4A0ABQ33581322-96E368A6-777E-4794-AFF0-A6CE9ED5F316Q33643957-157BA16B-B6F2-4AC1-B64B-116535D7258DQ33829857-E1D3FB45-7A93-4650-BA6F-F4F2BB83B517Q33915293-A3D18911-5A98-4090-BBEF-2948E820DC46Q34059983-0FD8085D-CDC7-46DC-AC56-D3DFCED302B2Q34073973-A9876922-8E98-47E5-ADAB-0844B28695BCQ34121078-21270636-966B-48BF-B174-21B857E8497AQ34361348-F7B20D07-F69A-4DCD-9CFD-3B47ACAA2A78Q34555664-EB10FA40-150E-43B2-B316-FA282737CF0BQ35125733-7AB2751D-1778-4DF0-B12E-7E6CA1577139Q35154327-9A0D0E2F-B391-4572-84BF-ECD60F673462Q35753968-939E4208-36FC-4CF1-BC1C-F0C4660D47C2Q35909661-9A7861AB-87B6-460F-AC12-9DD3C31451A8Q36134957-762FF689-DB38-407F-A84E-BCA41216F453Q36340124-BAD88EC2-9858-402A-82A8-C4A16C5FEB39Q36425161-8EBA14A7-97A9-41A2-8DDF-6ED49967967BQ36531228-25040837-9517-403A-8F32-3DF157A4CB08Q36691710-B8B73D15-1512-4539-8AB5-7584C1CAAA1CQ36757897-BAC406A6-E9BE-4422-BE30-0F0EE21440E6Q36936816-CFEF3579-B796-4BB9-9B27-2CE4B5306177Q36995765-F51D4E84-F480-4837-B08C-FB9E98A7698FQ37035277-F014FD93-EE66-4D87-8785-2B22A5A13C6EQ37151110-BA2B7576-EB17-4A55-919E-2BE029F12327Q37197686-5492B325-3626-4090-BA63-C74BE1324CA5Q37361497-77AC2F5F-BCD5-4E6A-8396-04F7F95B36CDQ37417967-B30669B8-7D32-4DDB-8F64-994401FA7023Q37418122-DD50DC97-7160-45CF-9787-E8D1929D0FE0Q37463638-BA903888-4E91-47AE-86A3-9AC6630029D6Q37705271-41D43D3D-FA87-4C0D-AA05-35C36A9B3FD5Q37852269-536EDBBC-CA31-48C2-B3FF-0120EA568FADQ38020241-8369D10E-F2C9-438E-834D-E061B2D93B13Q38032257-39FE40A8-DAC5-491A-BEEA-8D42443B228AQ38089241-57B2A09C-6375-495E-AF99-286B5219A282Q38122367-1249CC9F-0037-4F54-85B5-DB38288A7A45Q38967481-4B0FE005-6A8F-4D3F-AC36-B99C8449B352Q39763864-B91EFC17-7E94-4B6A-98B3-26EE3BB71AA3Q40109451-DE8E014A-3982-4FEC-98B3-93C7DE534CDCQ40612941-D6F89CA4-31F0-4A45-9472-3B5A8A42104BQ41839758-466A245D-2D09-47B8-8A24-4F01C5AF51FF
P2860
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical evaluation of a multi ...... r detection of bladder cancer.
@ast
Clinical evaluation of a multi ...... r detection of bladder cancer.
@en
Clinical evaluation of a multi ...... r detection of bladder cancer.
@nl
type
label
Clinical evaluation of a multi ...... r detection of bladder cancer.
@ast
Clinical evaluation of a multi ...... r detection of bladder cancer.
@en
Clinical evaluation of a multi ...... r detection of bladder cancer.
@nl
prefLabel
Clinical evaluation of a multi ...... r detection of bladder cancer.
@ast
Clinical evaluation of a multi ...... r detection of bladder cancer.
@en
Clinical evaluation of a multi ...... r detection of bladder cancer.
@nl
P2093
P1476
Clinical evaluation of a multi ...... r detection of bladder cancer.
@en
P2093
Daniel Burzon
Gary Bokinsky
Gerald Osher
Joseph Zadra
Julia A Bridge
Kerry Flom
Lawrence Yore
Mark Soloway
Michael F Sarosdy
Michael Lieber
P304
P356
10.1016/S0022-5347(05)64270-X
P407
P577
2002-11-01T00:00:00Z